- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Aethl Bio Appoints Dr. Joseph Maroon to Scientific Advisory Board
Appointment strengthens clinical and scientific leadership at the Pittsburgh-based biotech company
Published on Feb. 6, 2026
Got story updates? Submit your updates here. ›
Aethl Bio, a Pittsburgh-based biotechnology company developing next-generation platforms at the intersection of wound care and wellness, has announced the appointment of Dr. Joseph Maroon, MD, FACS, to its Scientific Advisory Board. Dr. Maroon is a respected neurosurgeon and physician-scientist who has spent decades advancing the understanding of brain injury, recovery, and human performance.
Why it matters
Dr. Maroon's appointment is seen as a validation of Aethl Bio's platform and mission, as he has dedicated his career to protecting and restoring critical human tissues. His expertise in oxygen-based therapies and recovery science aligns with Aethl Bio's focus on developing advanced oxygen-based solutions to address limitations in healing and recovery.
The details
Aethl Bio is developing its platform technology to deliver biologically relevant oxygen in formats intended to support tissue repair, resilience, and long-term health. Dr. Maroon's guidance will support the company's platform development, translational research strategy, and long-term clinical positioning as it advances pre-clinical validation, regulatory strategy, and clinical partnerships.
- Aethl Bio announced the appointment on February 6, 2026.
The players
Aethl Bio
A Pittsburgh-based biotechnology company developing next-generation platforms at the intersection of wound care and wellness.
Dr. Joseph Maroon
A respected neurosurgeon and physician-scientist who has spent decades advancing the understanding of brain injury, recovery, and human performance. He serves as a Clinical Professor of Neurological Surgery at UPMC and is widely recognized as the long-time neurosurgeon for the Pittsburgh Steelers.
Carmelo R. Montalvo
The CEO of Aethl Bio.
What they’re saying
“Dr. Maroon's decision to join Aethl Bio is a powerful validation of our platform and mission.”
— Carmelo R. Montalvo, CEO of Aethl Bio
“Throughout my career, I've focused on therapies that address inflammation and the root causes of injury and degeneration. Aethl Bio's approach aligns with that philosophy. Their platform represents a thoughtful and promising advancement in how we think about oxygen, healing, and recovery.”
— Dr. Joseph Maroon
The takeaway
Dr. Maroon's appointment to Aethl Bio's Scientific Advisory Board is a significant endorsement of the company's work in developing advanced oxygen-based solutions for wound care and wellness applications. His expertise in neurosurgery, recovery science, and the clinical application of oxygen-based therapies will be invaluable as Aethl Bio advances its platform and pursues regulatory approvals and clinical partnerships.
